首页> 外文期刊>Wiener klinische Wochenschrift >The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD
【24h】

The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD

机译:COPD患者血管紧张素转换酶基因型与肺动脉压之间的关系

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: The insertion (I)/deletion (D) polymorphism of the angiotensin-converting enzyme (ACE) gene has been associated with an increased risk of cardiovascular diseases. In patients with primary pulmonary hypertension, the homozygous ACE DD genotype is more prevalent than the non-DD genotype. However, the relationship of ACE gene polymorphism to secondary pulmonary hypertension remains unclear, and ethnicity may be one of the factors that can modulate the effects of ACE genotypes reported in different studies. We hypothesized that in patients with chronic obstructive pulmonary disease (COPD) the presence of the D allele in the ACE gene polymorphism is associated with increased pulmonary artery pressure (Ppa). PATIENTS AND METHODS: Bodyplethysmography was used to assess lung function in 66 consecutive patients with COPD; pulmonary artery pressures were determined using echocardiography. ACE gene I/D polymorphism was identified with the polymerase chain reaction. 118 healthy persons served as the control group. All patients and controls were Caucasian. Genotype II was identified in 15 patients with COPD, genotype ID in 31 and genotype DD in 20. In the control group, genotype II was identified in 19 persons, genotype ID in 68 and genotype DD in 31. The distribution of ACE gene polymorphism did not differ between patients and the control group. RESULTS: In patients with COPD, no differences were seen between the three genotype groups in mean age, smoking history, hemoglobin concentrations or ventilometric or blood gas variables. Both systolic and mean Ppa differed significantly between the II, ID and DD groups (systolic Ppa, 24.4 ± 2.2 versus 31.3 ± 2.5 and 36.7 ± 3.9 mmHg, respectively, ANOVA, p < 0.05; mean Ppa, 13.0 ± 1.5 versus 17.5 ± 1.4 and 21.2 ± 2.8 mmHg, respectively, ANOVA, p < 0.05). In multiple linear regression analysis, the I/D ACE gene polymorphism (p < 0.05), SaO2 (p < 0.05) and the duration of COPD (p < 0.02) were independent predictors of systolic and mean Ppa. CONCLUSION: The results of the study suggest that I/D ACE gene polymorphism is linked to pulmonary artery pressure in Caucasian patients with COPD.
机译:目的:血管紧张素转化酶(ACE)基因的插入(I)/缺失(D)多态性与心血管疾病的风险增加有关。在原发性肺动脉高压患者中,纯合子ACE DD基因型比非DD基因型更为普遍。然而,ACE基因多态性与继发性肺动脉高压的关系尚不清楚,种族可能是不同研究中报道的调节ACE基因型影响的因素之一。我们假设在患有慢性阻塞性肺疾病(COPD)的患者中,ACE基因多态性中D等位基因的存在与肺动脉压(Ppa)升高有关。患者和方法:人体容积描记法用于评估66例连续性COPD患者的肺功能。使用超声心动图确定肺动脉压。 ACE基因I / D多态性通过聚合酶链反应鉴定。对照组118例。所有患者和对照均为白种人。在15例COPD患者中鉴定出II型,在基因型ID中检出31例,在DD基因型中检出20例。在对照组中,在19人中鉴定出II型基因,在68例中鉴定出ID II型,在31例中鉴定出DD型。ACE基因多态性的分布确实患者与对照组之间没有差异。结果:在COPD患者中,三个基因型组在平均年龄,吸烟史,血红蛋白浓度或通气量或血气变量方面无差异。 II,ID和DD组之间的收缩压和平均Ppa均显着不同(收缩压Ppa分别为24.4±2.2和31.3±2.5和36.7±3.9 mmHg,方差分析,p <0.05;平均Ppa分别为13.0±1.5和17.5±1.4分别为21.2±2.8 mmHg和ANOVA,p <0.05)。在多元线性回归分析中,I / D ACE基因多态性(p <0.05),SaO2 (p <0.05)和COPD持续时间(p <0.02)是收缩压和平均Ppa的独立预测因子。结论:研究结果表明I / D ACE基因多态性与白种人COPD患者的肺动脉压有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号